D-1281-2019 Class II Terminated

Recalled by Preferred Pharmaceuticals, Inc — Anaheim, CA

Recall Details

Product Type
Drugs
Report Date
May 22, 2019
Initiation Date
April 30, 2019
Termination Date
April 3, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity

Product Description

Losartan Potassium Tab. USP 50mg, a) 30 count bottle (NDC 68788-0048-03) and b) 90 count bottle (NDC 68788-0048-09), Rx only, Preferred Pharmaceuticals, Inc., Anaheim, CA, Mfg: Torrent Pharma Inc., Basking Ridge, NJ

Reason for Recall

CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level at the manufacturer

Distribution Pattern

CA, GA, IN. No DOD/VA accounts. No foreign accounts.

Code Information

a) 30 tablets: lot A1818G batch 01181807 exp 3/2020; b) 90 tablets: lot L0517L batch 12051712 exp 3/2020